Back to Newsroom
Back to Newsroom

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HL, RMED and DBD

Wednesday, 17 July 2019 04:30 PM

The Klein Law Firm

Topic:
5

NEW YORK,NY / ACCESSWIRE / July 17, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Hecla Mining Company (NYSE: HL)
Class Period: March 19, 2018 to May 8, 2019
Lead Plaintiff Deadline: July 23, 2019

Throughout the class period, Hecla Mining Company allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) the Nevada operations were hemorrhaging cash due to a multitude of material problems identified by Defendants during Hecla’s extensive due diligence of the Nevada mines before the Class Period, and (b) as a result of these material problems, Defendants had no reasonable basis for their representations that the Nevada operations would be in a position to have positive or self-funding cash flow.

Learn about your recoverable losses in HL: http://www.kleinstocklaw.com/pslra-1/hecla-mining-company-loss-submission-form?id=2464&from=1

Ra Medical Systems, Inc. (NYSE: RMED)
Class Period: stockholders that purchased Ra Medical securities pursuant and/or traceable to the Company’s September 2018 initial public offering.
Lead Plaintiff Deadline: August 6, 2019

During the class period, Ra Medical Systems, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s evaluation of sales personnel candidates was inadequate; (2) the Company’s training program for sales personnel was inadequate; (3) as a result, the Company could not reasonably assure that its newly hired sales personnel were adequately experienced; (4) as a result, the Company would suffer a shortage of qualified sales personnel; (5) the Company’s manufacturing process could not reasonably support increased catheter production; (6) as a result, the Company would suffer production delays; and (7) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in RMED: http://www.kleinstocklaw.com/pslra-1/ra-medical-systems-inc-loss-submission-form?id=2464&from=1

Diebold Nixdorf, Incorporated (NYSE: DBD)
Class Period: February 14, 2017 to July 4, 2017
Lead Plaintiff Deadline: September 3, 2019

The lawsuit alleges Diebold Nixdorf, Incorporated made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) that, as a result of the Wincor acquisition and related integration, the Company was less focused on its core business; (2) that the Company expected certain customers would not renew their service contracts (i.e. contract runoff); (3) that the Company was not adequately prepared to staff service technicians; (4) that, as a result of the expected contract runoff, the Company would suffer a shortage of adequately trained service technicians; (5) that, as a result, the Company would suffer margin pressure in its services segment; (6) that, as a result of the foregoing, the Company would lose market share; and (7) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in DBD: http://www.kleinstocklaw.com/pslra-1/diebold-nixdorf-incorporated-loss-submission-form?id=2464&from=1

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

Topic:
5
Back to newsroom
Back to Newsroom
Share by: